Prospective study of predictive markers in nivolumab immunotherapy
Not Applicable
Recruiting
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000024051
- Lead Sponsor
- agasaki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
ruled unfit to this study by attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relationship between efficacy of nivolumab and immune complexes
- Secondary Outcome Measures
Name Time Method